GR3021557T3 - Chiral 1,5-diiodo-2-methoxy or benzyloxy intermediates - Google Patents

Chiral 1,5-diiodo-2-methoxy or benzyloxy intermediates

Info

Publication number
GR3021557T3
GR3021557T3 GR960402934T GR960402934T GR3021557T3 GR 3021557 T3 GR3021557 T3 GR 3021557T3 GR 960402934 T GR960402934 T GR 960402934T GR 960402934 T GR960402934 T GR 960402934T GR 3021557 T3 GR3021557 T3 GR 3021557T3
Authority
GR
Greece
Prior art keywords
diiodo
benzyloxy
chiral
intermediates
methoxy
Prior art date
Application number
GR960402934T
Other languages
Greek (el)
English (en)
Inventor
Daniela Faiardi
Alberto Bargiotti
Maria Grandi
Antonino Suarato
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928654A external-priority patent/GB8928654D0/en
Priority claimed from GB909007513A external-priority patent/GB9007513D0/en
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of GR3021557T3 publication Critical patent/GR3021557T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/313—Compounds having groups containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
GR960402934T 1989-12-19 1996-11-06 Chiral 1,5-diiodo-2-methoxy or benzyloxy intermediates GR3021557T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898928654A GB8928654D0 (en) 1989-12-19 1989-12-19 Preparation of 2-methoxy-4-morpholinyl anthracyclines
GB909007513A GB9007513D0 (en) 1990-04-03 1990-04-03 Morpholinyl derivatives of doxorubicin and process for their preparation

Publications (1)

Publication Number Publication Date
GR3021557T3 true GR3021557T3 (en) 1997-02-28

Family

ID=26296395

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402934T GR3021557T3 (en) 1989-12-19 1996-11-06 Chiral 1,5-diiodo-2-methoxy or benzyloxy intermediates

Country Status (28)

Country Link
EP (1) EP0434960B1 (show.php)
JP (1) JP3300342B2 (show.php)
KR (1) KR0183033B1 (show.php)
CN (2) CN1024922C (show.php)
AT (1) ATE143023T1 (show.php)
AU (1) AU636429B2 (show.php)
CA (1) CA2046857C (show.php)
CZ (1) CZ281949B6 (show.php)
DE (1) DE69028610T2 (show.php)
DK (1) DK0434960T3 (show.php)
ES (1) ES2094136T3 (show.php)
FI (1) FI97389C (show.php)
GR (1) GR3021557T3 (show.php)
HR (1) HRP921226B1 (show.php)
HU (2) HU209433B (show.php)
IE (1) IE81174B1 (show.php)
IL (3) IL111527A (show.php)
MY (1) MY119192A (show.php)
NO (2) NO175533C (show.php)
NZ (1) NZ243695A (show.php)
PT (1) PT96226B (show.php)
RU (1) RU2100366C1 (show.php)
SI (1) SI9012379B (show.php)
SK (1) SK278994B6 (show.php)
TW (1) TW208019B (show.php)
UA (1) UA27108A1 (show.php)
WO (1) WO1991009046A1 (show.php)
YU (1) YU48136B (show.php)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843903A (en) * 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
AU767394C (en) * 1999-12-29 2005-04-21 Immunogen, Inc. Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
CN101134119A (zh) 2002-05-24 2008-03-05 血管技术国际股份公司 用于涂覆医用植入物的组合物和方法
AU2003275263A1 (en) 2002-09-26 2004-04-19 Angiotech International Ag Perivascular wraps
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
MXPA05009849A (es) * 2003-03-18 2005-12-06 Pharmacia Italia Spa Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2.
CA2658146A1 (en) * 2006-07-12 2008-01-17 Nerviano Medical Sciences S.R.L. Crystalline nemorubicin hydrochloride
EP2277884B1 (en) * 2008-04-11 2017-08-23 Tianjin Hemay Oncology Pharmaceutical Co., Ltd Anthracycline antibiotic derivatives with high activity, preparation methods and uses thereof
CN101353361B (zh) * 2008-08-08 2011-06-01 中国人民解放军第四军医大学 一种阿霉素前体药物的制备方法及其应用
EP2646456B1 (en) * 2010-12-02 2015-01-21 Nerviano Medical Sciences S.r.l. Process for the preparation of morpholinyl anthracycline derivatives
CN105164138B (zh) 2013-04-29 2017-11-07 内尔维阿诺医学科学有限公司 新吗啉基蒽环类抗生素衍生物
WO2015089268A1 (en) 2013-12-11 2015-06-18 University Of Massachusetts Compositions and methods for treating disease using salmonella t3ss effector protein (sipa)
RU2715902C2 (ru) 2014-11-05 2020-03-04 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Функционализированные производные морфолинилантрациклина
CN115043895A (zh) * 2022-07-15 2022-09-13 戊言医药科技(上海)有限公司 一种pnu-159682及其中间体的制备方法
EP4572798A1 (en) * 2022-08-15 2025-06-25 Synaffix B.V. Anthracyclins and conjugates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883443A (en) * 1956-07-13 1959-04-21 Ruetschi Karl Lead-acid storage battery
US4423123A (en) * 1980-04-17 1983-12-27 Shin-Kobe Electric Machinery Co., Ltd. Electric storage battery and a method of making the same
JPS57163393A (en) * 1981-03-27 1982-10-07 Microbial Chem Res Found Novel anthracyclin derivative and its preparation
US4363857A (en) * 1981-10-16 1982-12-14 General Motors Corporation Laminated metal-plastic battery grid
US4710564A (en) * 1985-01-18 1987-12-01 Microbial Chemistry Research Foundation Anthracycline compounds
GB2172594B (en) * 1985-03-22 1988-06-08 Erba Farmitalia New morpholino derivatives of daunorubicin and doxorubicin
JPS6215323A (ja) * 1986-02-14 1987-01-23 Dainippon Ink & Chem Inc 微多孔中空繊維の製造法
US4861836A (en) * 1986-12-23 1989-08-29 Daikin Industries Ltd. Novel, iodine-containing compound, preparation thereof and block copolymer comprising the same

Also Published As

Publication number Publication date
CA2046857A1 (en) 1991-06-20
SI9012379B (sl) 2000-02-29
FI913887A0 (fi) 1991-08-16
CZ281949B6 (cs) 1997-04-16
HUT60232A (en) 1992-08-28
UA27108A1 (uk) 2000-02-28
SI9012379A (en) 1997-12-31
NO913176D0 (no) 1991-08-14
NZ243695A (en) 1993-06-25
NO940831L (no) 1991-08-14
IL111527A (en) 1998-02-22
CA2046857C (en) 2001-06-12
NO175533C (no) 1994-10-26
ATE143023T1 (de) 1996-10-15
HUT59693A (en) 1992-06-29
AU636429B2 (en) 1993-04-29
NO175533B (no) 1994-07-18
IL111527A0 (en) 1995-01-24
DE69028610D1 (de) 1996-10-24
WO1991009046A1 (en) 1991-06-27
HRP921226B1 (en) 1998-10-31
YU48136B (sh) 1997-05-28
CZ621990A3 (en) 1997-01-15
HU208148B (en) 1993-08-30
KR920701228A (ko) 1992-08-11
CN1053238A (zh) 1991-07-24
EP0434960A1 (en) 1991-07-03
SK621990A3 (en) 1998-05-06
PT96226B (pt) 1998-06-30
HRP921226A2 (en) 1995-12-31
TW208019B (show.php) 1993-06-21
PT96226A (pt) 1991-09-30
CN1039708C (zh) 1998-09-09
NO913176L (no) 1991-08-14
NO176911C (no) 1995-06-21
HU9200656D0 (en) 1992-05-28
CN1024922C (zh) 1994-06-08
IL96643A (en) 1995-01-24
AU6919491A (en) 1991-07-18
IL96643A0 (en) 1991-09-16
NO176911B (no) 1995-03-13
CN1079215A (zh) 1993-12-08
RU2100366C1 (ru) 1997-12-27
HU209433B (en) 1994-06-28
MY119192A (en) 2005-04-30
DE69028610T2 (de) 1997-02-06
DK0434960T3 (da) 1996-10-14
YU237990A (sh) 1993-05-28
NO940831D0 (no) 1994-03-09
EP0434960B1 (en) 1996-09-18
JPH04503679A (ja) 1992-07-02
IE81174B1 (en) 2000-06-14
FI97389B (fi) 1996-08-30
HU912994D0 (en) 1992-01-28
IE904543A1 (en) 1991-06-19
JP3300342B2 (ja) 2002-07-08
KR0183033B1 (ko) 1999-04-01
FI97389C (fi) 1996-12-10
SK278994B6 (sk) 1998-05-06
ES2094136T3 (es) 1997-01-16

Similar Documents

Publication Publication Date Title
FI905575A0 (fi) Ny polypeptidfoerening och foerfarande foer dess framstaellning.
DK0434960T3 (da) Chirale 1,5-diiod-2-methoxy- eller benzyloxymellemprodukter
ZA911502B (en) A pharmaceutical solution
AU4523797A (en) Atherosclerosis treatment
AU3744397A (en) Total synthesis of antitumor acylfulvenes
AU9281198A (en) Benzofuran derivatives
HUT73437A (en) Novel pyrrolocarbazoles
GR3031781T3 (en) Antifungal sordaridin derivatives
TW278071B (show.php)
EP0669336A4 (en) NEW CEPHEM DERIVATIVES.
DE69000019D1 (en) 4'-epi-4'-aminoanthracycline.
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents